Showing posts with label Olahraga. Show all posts
Showing posts with label Olahraga. Show all posts

Exclusive: Huawei partner offered U.S. tech to Iran
















LONDON (Reuters) – An Iranian partner of Huawei Technologies Co Ltd, a Chinese company that has denied breaking U.S. sanctions, last year tried to sell embargoed American antenna equipment to an Iranian firm, according to documents and interviews.


The buyer – an Iranian mobile-phone operator – says it canceled the deal with Huawei when it learnt the items were subject to sanctions and before any equipment was delivered. Huawei, the world’s second-largest telecoms equipment maker, uses products from a U.S. company, Andrew LLC, in some of the systems it sells.












Documents reviewed by Reuters show that Soda Gostar Persian Vista, a Tehran-based supplier of Huawei equipment in Iran, had offered to sell to MTN Irancell 36 cellular tower antennas made by Andrew for 14,364 euros. The equipment was to be delivered in Tehran on February 3, 2012, to “Huawei warehouse ready for installation,” according to a MTN Irancell purchase order dated November 30, 2011.


Huawei, based in Shenzhen, China, has an agreement with CommScope Inc. in Hickory, N.C. – which owns Andrew – to purchase Andrew antennas and other equipment and use the products in Huawei systems, according to CommScope. The Andrew antennas were part of a large order for Huawei telecommunications gear that MTN Irancell had placed through Soda Gostar, the documents show.


Washington has banned the sale of U.S. technology to Iran for years. Huawei said in a statement that it complies with U.S. law and also requires third parties like Soda Gostar “to follow applicable laws and regulations.” This month, the U.S. House Intelligence Committee criticized Huawei for failing “to provide evidence to support its claims that it complies with all international sanctions or U.S. export laws.”


South Africa’s MTN Group, which owns 49 percent of MTN Irancell, said the Iranian telecoms firm had requested 36 German-made antennas not subject to sanctions but that “Huawei, through its local partner Soda Gostar, mistakenly provided details of U.S.-manufactured” antennas.


“This was later identified as an error and as a result the tender request was canceled with Huawei and the German goods obtained from a local reseller,” Paul Norman, MTN Group’s corporate affairs officer, said in a statement. He added, “The incident is illustrative of the strong processes in place in MTN and Irancell to ensure compliance” with U.S. sanctions.


In a statement, Vic Guyang, a Huawei spokesman, acknowledged that MTN Irancell had canceled the order. He added, “We did not participate in the delivery of this project because Huawei has been and continues to be in strict compliance with all relevant international and local laws and regulations.” Officials at Soda Gostar could not be reached for comment.


Rick Aspan, a spokesman for CommScope, said the company was not aware of the aborted transaction. “Obviously we’re going to look into this a little further,” he said.


He described Huawei as a major customer of antennas and other CommScope telecommunications equipment. “They purchase certain CommScope products that they incorporate into the systems they’re making for their wireless operator customers,” he said. CommScope manufactures its products in a number of countries, including China.


Reuters has documented how China has become a backdoor way for Iran to obtain embargoed U.S. computer equipment. In March and April, Reuters reported that China’s ZTE Corp, a Huawei competitor, had sold or agreed to sell millions of dollars worth of U.S. computer gear to Telecommunication Co. of Iran, the country’s largest telecommunications firm, and a unit of the consortium that controls TCI. The articles sparked investigations by the U.S. Commerce Department and the Justice Department.


In a filing this month with the Hong Kong stock exchange, ZTE said it was cooperating with the investigations.


Reuters has also documented how MTN procured U.S. computer equipment through a network of companies in Iran and the Middle East when it launched MTN Irancell in 2006. MTN employees created presentations for meetings and wrote reports that openly discussed circumventing U.S. sanctions to source the equipment, Reuters reported in August.


(Edited by Simon Robinson)


Tech News Headlines – Yahoo! News



Read More..

Economy is healing – Chancellor Osborne
















LONDON (Reuters) – Chancellor George Osborne said on Thursday the latest GDP data showed the economy was on the mend but there were still challenges ahead due to weak data coming from the euro zone.


Figures released on Thursday showed Britain pulled out of recession in the third quarter, posting its strongest quarterly gross domestic product growth in five years.












“There is still a long way to go, but these figures show we are on the right track,” Osborne said in a statement. “This (is) another sign that the economy is healing …”


He added however: “Yesterday’s weak data from the euro zone were a reminder that we still face many economic challenges at home and abroad.”


The Office for National Statistics said Britain’s gross domestic product rose by 1.0 percent between July and September, beating forecasts for a 0.6 percent gain, after shrinking by 0.4 percent between April and June.


On the year, the economy was flat, better than expected.


(Reporting By Maria Golovnina; editing by Steve Addison)


Economy News Headlines – Yahoo! News



Read More..

“American Idol”, “Touch”, “The Following” get premiere dates
















LOS ANGELES (TheWrap.com) – Fox released its midseason premiere dates Wednesday, announcing the returns of “American Idol” and the Kiefer Sutherland drama “Touch,” as well as the debut of the Kevin Bacon thriller “The Following.”


American Idol” will kick off its 12th season, with new judges Mariah Carey, Nicki Minaj and Keith Urban, with a two-night premiere on Wednesday, January 16 and Thursday, January 17 at 8 p.m.












“The Following,” which was created by “The Vampire Diaries” and “Scream” vet Kevin Williamson, will premiere Monday, January 21 at 9 p.m. The series stars Kevin Bacon as a former FBI agent who’s drawn out of retirement to track down a serial murderer who leads an expanding web of killers.


“Touch,” which had its Season 2 premiere bumped from October 26 in order to afford the show better promotional opportunities, will now return on Friday, February 1 at 9 p.m.


TV News Headlines – Yahoo! News



Read More..

Sanofi sees relief from patent loss pain
















PARIS (Reuters) – French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries.


Sanofi said on Thursday full-year earnings could fall 12 percent, compared with its previous guidance for a decline of up to 15 percent, helped also by demand from emerging markets.












“We are seeing the light at the end of the tunnel,” chief executive Chris Viehbacher told reporters after third-quarter income dropped less than expected.


“As our growth platforms continue to build steam, we believe this will put Sanofi back on a growth trajectory,” he added.


Sanofi has seen sales of blockbusters such as blood clot preventer Plavix nearly wiped out by the loss of patent protection. Plavix was the world’s second-biggest-selling medicine until its U.S. patent lapsed in May.


It expects to return to growth from next year thanks to emerging markets, diabetes, vaccines, animal health, biotech drugs and new products such bowel cancer drug Zaltrap and multiple sclerosis pill Aubagio.


Sanofi’s better than expected third quarter and improved guidance contrast with bleak quarterly earnings from European rivals, which are also facing headwinds from a wave of patent expiries sweeping through the global pharmaceutical industry.


Switzerland’s Novartis reported lower-than-expected third-quarter sales on Thursday, dragged down by a patent loss on top-selling blood pressure drug Diovan and lower sales at its generics unit.


Sales at AstraZeneca slumped by a bigger-than-expected 19 percent in the third quarter.


“Sanofi should be capable of returning to very consistent revenue and EPS growth over the long-term, which makes it unique among its peers,” said Bernstein analyst Tim Anderson.


DOUBLE-DIGIT GROWTH


In the three months to September 30, Sanofi’s business net income, which excludes items such as amortization and legal costs, fell 7.4 percent to 2.22 billion euros ($ 2.9 billion), beating the average forecast of 1.97 billion in a Reuters poll.


Double-digit percentage growth in diabetes treatment Lantus and rare disease unit Genzyme as well as the weaker euro lifted sales to 9.04 billion, up 3.3 percent, offsetting the slump in Plavix and cancer treatment Eloxatin due to generic competition.


Sales in emerging markets, one area Sanofi is betting on for future growth, provided a cushion to the overall results, though they grew slower than in the previous quarter – up 6.8 percent compared with 9.8 percent in the second quarter – due to a lower contribution from Asia and Latin America.


Sanofi shares were up 1.9 percent at 67.35 euros by 0815 GMT, outperforming France’s benchmark CAC 40 index.


The shares have risen around 17 percent since the start of 2012, giving the company a market capitalization of over 87 billion euros, close to toppling its former parent, oil company Total, as the largest company on the CAC 40.


($ 1 = 0.7711 euros)


(Editing by Christian Plumb and Mark Potter)


Medications/Drugs News Headlines – Yahoo! News



Read More..